Evaluation of soft-tissue lesions with F-18-FDG PET/CT: initial results of a prospective trial

Autor(es)

Leal, Aline L. ^{[1, 2]} ; Etchebehere, Mauricio ^[3] ; Santos, Allan O. ^{[1, 2]} ; Kalaf, Gustavo ^[4] ; Pacheco, Elisa B. ^[5] ; Amstalden, Eliane M. ^[6] ; Etchebehere, Elba C. ^{[1, 2]}

Afiliação do(s) autor(es)

^[1] Campinas State Univ UNICAMP, Dept Radiol, Div Nucl Med, BR-13083888 Campinas, SP - Brazil

^[2] Nucl Med Campinas MN&D, Campinas, SP - Brazil

^[3] Campinas State Univ UNICAMP, Dept Orthopaed, BR-13083888 Campinas, SP - Brazil

^[4] Campinas Radiol Clin RCC, Campinas, SP - Brazil

^[5] Campinas State Univ UNICAMP, Dept Radiol, BR-13083888 Campinas, SP - Brazil

^[6] Campinas State Univ UNICAMP, Dept Pathol, BR-13083888 Campinas, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: NUCLEAR MEDICINE COMMUNICATIONS; v. 35, n. 3, p. 252-259, MAR 2014.
• Citações Web of Science: 5

Resumo

Purpose of the reportAlthough MRI is utilized for planning the resection of soft-tissue tumors, it is not always capable of differentiating benign from malignant lesions. The risk of local recurrence of soft-tissue sarcomas is increased when biopsies are performed before resection and by inadequate resections. PET associated with computed tomography using fluorodeoxyglucose labeled with fluorine-18 (F-18-FDG PET/CT) may help differentiate between benign and malignant tumors, thus avoiding inadequate resections and making prior biopsies unnecessary. The purpose of this study was to evaluate the usefulness of F-18-FDG PET/CT in differentiating benign from malignant solid soft-tissue lesions.Materials and methodsPatients with solid lesions of the limbs or abdominal wall detected by MRI were submitted to F-18-FDG PET/CT. The maximum standardized uptake value (SUVmax) cutoff was determined to differentiate malignant from benign tumors. Regardless of the F-18-FDG PET/CT results all patients underwent biopsy and surgery.ResultsMRI was performed in 54 patients, and 10 patients were excluded because of purely lipomatose or cystic lesions. F-18-FDG PET/CT was performed in the remaining 44 patients. Histopathology revealed 26 (59%) benign and 18 (41%) malignant soft-tissue lesions. A significant difference in SUVmax was observed between benign and malignant soft-tissue lesions. The SUVmax cutoff of 3.0 differentiated malignant from benign lesions with 100% sensitivity, 83.3% specificity, 89.6% accuracy, 78.3% positive predictive value, and 100% negative predictive value.Conclusion(18)F-FDG PET/CT seems to be able to differentiate benign from malignant soft-tissue lesions with good accuracy and very high negative predictive value. Incorporating F-18-FDG PET/CT into the diagnostic algorithm of these patients may prevent inadequate resections and unnecessary biopsies. (C) 2014 Wolters Kluwer Health | Lippincott Williams \& Wilkins. (AU)

• Processo FAPESP: 11/50255-0 - Avaliação da agressividade de lesões de partes moles com uso de PET/CT - FDG 18f
• Beneficiário: Elba Cristina Sá de Camargo Etchebehere
• Modalidade de apoio: Auxílio à Pesquisa - Regular